Antibiotics are considered one of the most important revolutions not only in the healthcare sector, but also in food, veterinary, agricultural, and industry. They have contributed to the development of modern medicine, especially in reducing mortality rates and doubling life expectancy. Today, they are seriously threatened by the phenomenon of antimicrobial resistance (AMR), which indicates the ability of microorganisms to become increasingly resistant to an antimicrobial to which they were previously sensitive. AMR is a natural phenomenon, caused by natural selection and genetic mutation, however, there are additional social pressures accelerating it.
Antimicrobial diagnostics and management, along with vaccinations, are essential in combating AMR and reducing the impacts of infectious diseases.
Papers
- The Value of Prevention for Economic Growth and the Sustainability of Healthcare, Social, and Welfare Systems
- La vaccinazione anti-pneumococcica nell’adulto: quali impatti per il sistema
- Antimicrobial resistance: a public health priority
- Italians and vaccines in the post-Covid19 era: trust or skepticism?
- Il contrasto dell’antimicrobico resistenza: il valore dell’innovazione nella diagnostica
- Le vaccinazioni ai tempi del COVID-19
- L'influenza e il valore della vaccinazione antinfluenzale
- Malattie infettive e prevenzione vaccinale in Puglia
- COVID-19, 3 anni dopo - Dagli impatti sulla salute e sul SSN al contributo della vaccinazione. Ripartire nella nuova normalità
Planetary Health and AMR - November 23, 2022
